[Cardiovascular activity of triethylamine nitrosopentacyanoferrate].
D000284:Administration, Oral; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002496:Central Venous Pressure / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D005021:Ethylamines / Q000008:administration & dosage / Q000633:toxicity; D005292:Ferricyanides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology / Q000633:toxicity*; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D051379:Mice; D009603:Nitroso Compounds / Q000008:administration & dosage / Q000633:toxicity; D051381:Rats; D013053:Spectrophotometry; D013055:Spectrophotometry, Infrared
D005021:Ethylamines; D005292:Ferricyanides; D009603:Nitroso Compounds
Activité cardiovasculaire du nitrosopentacyanoferrate de triéthylamine.